Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Adaptive Biotechnologies Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
Adaptive Biotechnologies Corp has 2 disclosed suppliers and 4 disclosed customers. Each one is named in an SEC filing, either Adaptive Biotechnologies Corp’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“On August 13, 2025, our worldwide collaboration and license agreement with Genentech, Inc. ("Genentech") (the "Genentech Agreement") was terminated, with termination effective February 9, 2026.”
FILING10-K0001193125-26-076902cik 0001478320
“For example, we have purchased the Illumina NextSeq and NovaSeq X Plus systems, and Illumina, Inc. ("Illumina") also supplies us with reagents that have been designed for use solely with this sequencer.”
FILING10-K0001193125-26-076902cik 0001478320
“In December 2025, we entered into two non-exclusive agreements with Pfizer Inc. ("Pfizer") to leverage proprietary TCR discovery platform and its large‑scale immune receptor–antigen mapping datasets to accelerate therapeutic research in rheumatoid arthritis ("RA") and broader immunology applications.”
FILING10-K0001193125-26-076902cik 0001478320
“Early work by Dr. Robins with Fred Hutch led to discoveries around immunosequencing methods and tools covered by multiple patents and patent applications in the U.S. and abroad which we exclusively licensed.”
FILING10-K0001193125-26-076902cik 0001478320
“clonoSEQ MRD testing has now been enabled in 173 sites on the Epic System Corporation's ("Epic") comprehensive electronic medical record ("EMR") system, through Flatiron Health, Inc.'s ("Flatiron") OncoEMR ® and on other EMRs to enable easier test workflow and follow-up to facilitate more routine access to patients.”
FILING10-K0001193125-26-076902cik 0001478320
“clonoSEQ MRD testing has now been enabled in 173 sites on the Epic System Corporation's ("Epic") comprehensive electronic medical record ("EMR") system, through Flatiron Health, Inc.'s ("Flatiron") OncoEMR ® and on other EMRs to enable easier test workflow and follow-up to facilitate more routine access to patients.”
FILING10-K0001193125-26-076902cik 0001478320
Watchlist prices, news filtered to it, and its next report on your desk.
ADPT (Adaptive Biotechnologies Corp) has 2 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.